A
Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
LSE:APH
Price:
33.1 GBX
-1.78%
Market Closed
Updated:
May 5, 2024
Alliance Pharma PLC
Cash from Operating Activities
|
Alliance Pharma PLC
Cash from Operating Activities Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash from Operating Activities
£29.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Operating Activities
£6.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Operating Activities
$10.3B
|
CAGR 3-Years
29%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Operating Activities
-$315m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Operating Activities
$608m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Operating Activities
£63.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
See Also
What is Alliance Pharma PLC's Cash from Operating Activities?
Cash from Operating Activities
29.1m
GBP
29.1m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Cash from Operating Activities amounts to 29.1m GBP.
What is Alliance Pharma PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
10%
Over the last year, the Cash from Operating Activities growth was -14%. The average annual Cash from Operating Activities growth rates for Alliance Pharma PLC have been -3% over the past three years , 2% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
